AGL - agilon health, inc.
NYSE
->
Healthcare
->
Medical Care Facilities
Long Beach,
United States
Type: Equity
AGL price evolution
AGL
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $114.33 | $178.54 | $201.19 | $404.39 |
| Short term investments | $380.77 | $395.88 | $389.05 | $422.49 |
| Net receivables | $942.46 | $1345.71 | $1417.05 | $1004.86 |
| Inventory | ||||
| Total current assets | $1480.08 | $1956.64 | $2044.84 | $1876.44 |
| Long term investments | ||||
| Property, plant & equipment | $27.58 | $26.2 | $24.41 | $22.13 |
| Goodwill & intangible assets | $87.9 | $155.04 | $156.32 | $154.85 |
| Total noncurrent assets | $260.79 | $321.43 | $308.08 | $293.83 |
| Total investments | $380.77 | $395.88 | $389.05 | $422.49 |
| Total assets | $1740.87 | $2278.07 | $2352.92 | $2170.27 |
| Current liabilities | ||||
| Accounts payable | $970.91 | $1296.33 | $1357.35 | $967.61 |
| Deferred revenue | ||||
| Short long term debt | $6.25 | $5 | $5 | $5 |
| Total current liabilities | $977.16 | $1301.33 | $1362.35 | $972.61 |
| Long term debt | $32.31 | $34.78 | $36.02 | $37.25 |
| Total noncurrent liabilities | $102.69 | $105.15 | $111.12 | $115.82 |
| Total debt | $38.56 | $39.78 | $41.02 | $42.25 |
| Total liabilities | $1079.85 | $1406.47 | $1473.47 | $1088.43 |
| Shareholders' equity | ||||
| Retained earnings | -$1326.83 | -$1096.39 | -$1064.96 | -$1048.21 |
| Other shareholder equity | -$2.3 | -$6.23 | -$6.37 | -$3.55 |
| Total shareholder equity | $661.84 | $872.37 | $880.17 | $1082.51 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $114.33 | $507.68 | $1054.82 | $135.18 |
| Short term investments | $380.77 | $411.9 | ||
| Net receivables | $942.46 | $497.57 | $293.41 | $144.56 |
| Inventory | ||||
| Total current assets | $1480.08 | $1451.27 | $1367.19 | $294.2 |
| Long term investments | ||||
| Property, plant & equipment | $27.58 | $33.08 | $9.16 | $6.46 |
| Goodwill & intangible assets | $87.9 | $109.22 | $96.94 | $102.01 |
| Total noncurrent assets | $260.79 | $246.19 | $219.06 | $152.16 |
| Total investments | $380.77 | $411.9 | ||
| Total assets | $1740.87 | $1697.47 | $1586.25 | $446.36 |
| Current liabilities | ||||
| Accounts payable | $970.91 | $183.36 | $351.96 | $260.11 |
| Deferred revenue | ||||
| Short long term debt | $6.25 | $5 | $5 | $3.04 |
| Total current liabilities | $977.16 | $535.09 | $356.96 | $266.83 |
| Long term debt | $32.31 | $38.48 | $43.4 | $64.67 |
| Total noncurrent liabilities | $102.69 | $121.77 | $137.7 | $154.76 |
| Total debt | $38.56 | $43.48 | $48.4 | $67.71 |
| Total liabilities | $1079.85 | $656.25 | $494.66 | $421.59 |
| Shareholders' equity | ||||
| Retained earnings | -$1326.83 | -$1064.23 | -$957.68 | -$551.19 |
| Other shareholder equity | -$2.3 | -$5.56 | ||
| Total shareholder equity | $661.84 | $1041.22 | $1091.9 | -$284.73 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $815.5 | $1215.66 | $1149.05 | $1136.15 |
| Cost of revenue | $910.8 | $1185.18 | $1091.86 | $1058.85 |
| Gross Profit | -$95.3 | $30.48 | $57.19 | $77.3 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $63.28 | $74.14 | $81.5 | $66.85 |
| Total operating expenses | $64.31 | $79.45 | $87.01 | $71.03 |
| Operating income | -$159.6 | -$48.97 | -$29.82 | $6.26 |
| Income from continuing operations | ||||
| EBIT | -$228.28 | -$28.57 | -$14.09 | $15.8 |
| Income tax expense | $0.27 | $1.21 | $1.07 | -$1.76 |
| Interest expense | $1.89 | $1.65 | $1.59 | $1.53 |
| Net income | ||||
| Net income | -$230.43 | -$31.44 | -$16.75 | $16.02 |
| Income (for common shares) | -$230.43 | -$31.44 | -$16.75 | $16.02 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4316.36 | $2708.21 | $1833.56 | $1218.33 |
| Cost of revenue | $4246.69 | $2595.93 | $1757.15 | $1124.18 |
| Gross Profit | $69.67 | $112.29 | $76.41 | $94.15 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $285.76 | $218.94 | $455.82 | $137.29 |
| Total operating expenses | $301.8 | $232.72 | $470.37 | $150.82 |
| Operating income | -$232.13 | -$120.43 | -$393.95 | -$56.67 |
| Income from continuing operations | ||||
| EBIT | -$255.15 | -$100.39 | -$399.45 | -$51.05 |
| Income tax expense | $0.79 | $1.64 | $0.89 | $0.86 |
| Interest expense | $6.66 | $4.53 | $6.15 | $8.13 |
| Net income | ||||
| Net income | -$262.6 | -$106.55 | -$406.49 | -$60.05 |
| Income (for common shares) | -$262.6 | -$106.55 | -$406.49 | -$60.05 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$230.43 | -$31.44 | -$16.75 | $16.02 |
| Operating activities | ||||
| Depreciation | $5.15 | $5.31 | $5.51 | $4.19 |
| Business acquisitions & disposals | $1.42 | -$0.11 | -$44.37 | |
| Stock-based compensation | $15.52 | $20.74 | $19.57 | $13.67 |
| Total cash flows from operations | -$61.17 | -$13.02 | -$21.2 | -$60.81 |
| Investing activities | ||||
| Capital expenditures | -$3.93 | -$4.09 | -$4.09 | -$3.72 |
| Investments | $11.76 | -$5.14 | $25.96 | -$2.73 |
| Total cash flows from investing | -$2.2 | -$11.03 | $20.03 | -$50.81 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.41 | $2.66 | -$200.79 | $9.59 |
| Net borrowings | -$1.25 | -$1.25 | -$1.25 | -$1.25 |
| Total cash flows from financing | -$0.84 | $1.41 | -$202.04 | $8.34 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$64.21 | -$22.64 | -$203.21 | -$103.29 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$262.6 | -$106.55 | -$406.49 | -$60.05 |
| Operating activities | ||||
| Depreciation | $20.16 | $13.77 | $14.67 | $14.1 |
| Business acquisitions & disposals | -$43.06 | $0.5 | -$1.34 | $26.2 |
| Stock-based compensation | $69.5 | $28.38 | $292.39 | $6.69 |
| Total cash flows from operations | -$156.2 | -$130.81 | -$148.16 | -$53.2 |
| Investing activities | ||||
| Capital expenditures | -$15.83 | -$15.43 | -$6.56 | -$1.77 |
| Investments | $29.86 | -$412.23 | -$75.74 | -$1.79 |
| Total cash flows from investing | -$44.02 | -$444.39 | -$90.51 | $22.07 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$188.13 | $33.06 | $1189.03 | $27.66 |
| Net borrowings | -$5 | -$5 | -$19.9 | -$3.04 |
| Total cash flows from financing | -$193.13 | $28.06 | $1154.39 | $24.62 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$393.35 | -$547.14 | $915.73 | -$6.52 |
News
Fundamentals
| Market cap | $2.19B |
|---|---|
| Enterprise value | $2.11B |
| Shares outstanding | 406.39M |
| Revenue | $4.32B |
|---|---|
| EBITDA | -$234.99M |
| EBIT | -$255.15M |
| Net Income | -$262.60M |
| Revenue Q/Q | 18.23% |
| Revenue Y/Y | 59.38% |
| P/E ratio | -8.33 |
|---|---|
| EV/Sales | 0.49 |
| EV/EBITDA | -8.98 |
| EV/EBIT | -8.27 |
| P/S ratio | 0.51 |
| P/B ratio | 3.29 |
| Book/Share | 1.63 |
| Cash/Share | 0.28 |
| EPS | -$0.65 |
|---|---|
| ROA | -12.30% |
| ROE | -30.04% |
| Debt/Equity | 1.63 |
|---|---|
| Net debt/EBITDA | -4.11 |
| Current ratio | 1.51 |
| Quick ratio | 1.51 |